ADMS

COM:ADAMASPHARMA

Supernus Pharmaceuticals

Stock

USD

Last Close

8.22

01/01 00:00

Volume Today

3.15M

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20
revenue	71.09M -	55.85M 21.45%	1.92M 96.57%	572K 70.15%	571K 0.17%	34.05M 5,862.52%	54.64M 60.48%	74.46M 36.28%
cost of revenue					17K -	633K 3,623.53%	2.47M 290.05%	2.04M 17.46%
gross profit	71.09M -	55.85M 21.45%	1.92M 96.57%	572K 70.15%	554K 3.15%	33.41M 5,931.23%	52.17M 56.13%	72.42M 38.83%
selling and marketing expenses
general and administrative expenses	6.67M -	15.47M 132.07%	23.46M 51.62%	30.33M 29.28%	61.31M 102.18%	109.14M 78.00%	114.37M 4.80%	106.84M 6.58%
selling general and administrative expenses	6.67M -	15.47M 132.07%	23.46M 51.62%	30.33M 29.28%	61.31M 102.18%	109.14M 78.00%	114.37M 4.80%	106.84M 6.58%
research and development expenses	7.41M -	21.86M 195.01%	35.90M 64.20%	31.23M 13.00%	27.17M 13.01%	39.30M 44.66%	30.03M 23.58%	9.75M 67.55%
other expenses
cost and expenses	14.08M -	37.33M 165.20%	59.35M 58.99%	61.56M 3.71%	88.50M 43.77%	149.07M 68.44%	146.87M 1.47%	118.63M 19.23%
operating expenses	14.08M -	37.33M 165.20%	59.35M 58.99%	61.56M 3.71%	88.48M 43.74%	148.44M 67.76%	144.40M 2.72%	116.59M 19.26%
interest expense	4.91M -				4.64M -	19.09M 311.02%	15.04M 21.20%	13.24M 12.00%
ebitda	57.08M -	17.75M 68.90%	-56.64M 419.06%	-59.37M 4.81%	-85.38M 43.82%	-110.45M 29.36%	-88.93M 19.48%	-43.31M 51.29%
operating income	57.02M -	18.51M 67.53%	-57.44M 410.24%	-60.98M 6.18%	-87.93M 44.18%	-115.02M 30.82%	-92.23M 19.81%	-44.16M 52.12%
depreciation and amortization	66K -	155K 134.85%	435K 180.65%	808K 85.75%	1.19M 47.77%	1.46M 22.28%	1.21M 16.85%	851K 29.90%
total other income expenses net	-4.91M -	-917K 81.31%	363K 139.59%	811K 123.42%	-3.29M 506.17%	-15.98M 385.03%	-12.95M 18.94%	-13.24M 2.22%
income before tax	52.11M -	17.60M 66.23%	-57.07M 424.34%	-60.17M 5.43%	-91.22M 51.60%	-131.00M 43.61%	-105.19M 19.70%	-57.40M 45.43%
income tax expense	1.19M -	7.37M 519.14%	-5.27M 171.49%	-115K 97.82%	-1.73M 1,404.35%	3.12M 280.06%	2.09M 32.81%
net income	50.92M -	10.22M 79.92%	-51.80M 606.72%	-60.06M 15.94%	-89.49M 49.01%	-131.00M 46.38%	-105.19M 19.70%	-57.40M 45.43%
weighted average shs out	13.41M -	14.84M 10.61%	18.11M 22.07%	21.71M 19.88%	22.56M 3.90%	26.89M 19.19%	27.68M 2.94%	35.17M 27.06%
weighted average shs out dil	15.79M -	17.11M 8.34%	18.11M 5.87%	21.71M 19.88%	22.56M 3.90%	26.89M 19.19%	27.68M 2.94%	35.17M 27.06%
eps	3.80 -	0.69 81.84%	-2.86 514.49%	-2.77 3.15%	-3.97 43.32%	-4.87 22.67%	-3.80 21.97%	-1.63 57.11%
epsdiluted	3.22 -	0.60 81.37%	-2.86 576.67%	-2.77 3.15%	-3.97 43.32%	-4.87 22.67%	-3.80 21.97%	-1.63 57.11%

All numbers in USD (except ratios and percentages)